Delray Beach, FL, March 28, 2025 (GLOBE NEWSWIRE) — The global Medical Humidifier Market, valued at US$878.4 million in 2023, is forecasted to grow at a robust CAGR of 5.6%, reaching US$922.8 million in 2024 and an impressive US$1,211.7 million by 2029. Increased admissions to intensive care (ICUs) and neonatal intensive care units (NICUs), especially for ventilator-dependent patients, increasing neonatal mortality & preterm birth rates, aging populations, and rising healthcare costs are shifting patient care from hospitals to home settings. Governments and private investors are expanding hospital networks, leading to higher demand for humidification devices, which drives market growth. Additionally, government and non-government initiatives in respiratory health and post-pandemic demand for respiratory care also offer opportunities for market growth.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247197989
Browse in-depth TOC on “Medical Humidifier Market”
265 – Tables
60 – Figures
293 – Pages
By Based on product, the medical humidifier market is segmented into Heated Humidifier, Bubble Humidifier, Heat and Moisture Exchangers (HMEs), and Humidifier Accessories. Among these, in 2023, Heat and Moisture Exchangers (HMEs) segment accounts for the highest growth rate in the Medical humidifier market. This is due to increasing surgical volumes worldwide, especially in developed and emerging economies, is fueling demand for anesthesia-related humidification devices, compared to active humidification systems, HMEs are more affordable, require no power source, and have low maintenance costs, HMEs enhance comfort for patients using CPAP and BiPAP machines for sleep apnea and chronic respiratory conditions, and growing healthcare access in Asia Pacific, Latin America, and the Middle East is driving the uptake of HMEs in newly built hospitals and homecare settings.
By patient type, the medical humidifier market is divided into three segments based on patient type: adult, pediatric, and neonatal. Among them, in 2023, adult patients segment accounts for the greatest market share of the medical humidifier market, since age-related loss of lung function necessitates the use of humidifiers in long-term oxygen treatment (LTOT), CPAP/BiPAP therapy, and home ventilation. Postoperative ventilation in adults undergoing surgeries (cardiac, neurological, and pulmonary) drives demand for heated humidifiers and heat moisture exchangers (HMEs), as does the growing elderly population (65 and older), who are more susceptible to chronic respiratory failure and pulmonary infections. According to the World Health Organization (2024), by 2030, one in every six individuals worldwide would be 60 or older, with the population in this age group expected to increase from 1 billion in 2020 to 1.4 billion. Furthermore, the number of people aged 80 and older is expected to triple between 2020 and 2025, reaching 424 million. The medical humidifier market is predicted to grow in line with the large growth in the aging population, especially among the elderly.
By geography, The medical humidifier market is segmented into six major regional segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. The north America accounts for the largest market share in the medical humidifier market in 2023. This is due to rising ICU admissions and ventilator use, which necessitate humidification systems for oxygen therapy and mechanical ventilation, ongoing development and commercialization of medical humidifier products, supportive government regulations for product commercialization, and significant investments in hospital infrastructure. For example, the World Bank Group predicts that in 2022, North America’s health expenditure will account for 16.6% of the region’s GDP, indicating a high commitment to healthcare infrastructure development. Additionally, the huge presence of medical humidifier manufacturing companies in the region is increasing the market growth in the region. These companies are investing heavily in research and developments thus providing technologically advanced medical humidifiers across the region thus contributing to the regional growth.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=247197989
Prominent players in the Medical humidifier market include, include ResMed Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Fisher & Paykel Healthcare Limited (New Zealand), Koninklijke Philips N.V. (Netherlands), Vincent Medical Holdings Limited (Hong Kong), Medline Industries, LP. (US), Hamilton Medical (Switzerland), GaleMed Corporation (Taiwan), and Eakin Healthcare (UK).
Fisher & Paykel Healthcare Limited (New Zealand):
Fisher & Paykel Healthcare Limited designs, manufactures, and markets products for respiratory care, acute care, and obstructive sleep apnea. The company primarily operates in three business segments: Hospital Products, Homecare Products, and Distributed and Other Products. The Hospital Products segment offers medical humidifier products. . They invest in research & development which helps in driving innovation and enhancing patient outcomes. By leveraging their huge product portfolio and global reach, they are maintaining dominance in the medical humidifier market across various geographies and healthcare settings. Fisher & Paykel Healthcare operates in over 120 countries worldwide. It adopted product launches and expansion as key strategies to increase its revenue. The recently launched F&P my820 system delivers heated humidification for a range of respiratory support therapies.
ResMed Inc. (US):
Leading worldwide in digital health, sleep apnea treatment, and respiratory care solutions, ResMed Inc. is also strongly apparent in ventilation and humidification technology. Together with continuous positive airway pressure (CPAP) devices, the firm designs and produces medical humidifiers, along with life support ventilators and bilevel positive airway pressure (BiPAP) devices. Two main divisions define the activities of the company: Sleep and Respiratory Care and Software as a Service (SaaS). Essential for the medical humidifiers market, the Respiratory Care section provides solutions meeting different patient needs. Serving sleep clinics, home healthcare providers, patients, and third-party payers, the company’s product range is offered in over 140 countries. Maintain its market share in respiratory care equipment, the company emphasizes on organic and inorganic development plans. For example, ResMed acquired Tong-il (South Korea), another top HME provider in South Korea for respiratory care and sleep.
Drägerwerk AG & Co. KGaA (Germany)
With its headquarters in Lübeck, Germany, Drägerwerk AG & Co. KGaA is globally recognised pioneer in medical and safety solutions. The Medical section consists of system solutions, tools, and services for acute point-of- care needs. Maintaining sales and service operations in almost 50 countries, the company ensures a wide visibility. Drägerwerk AG & Co. KGaA continues to prioritize innovation in product development and manufacturing medical humidifiers that satisfy the requirements for efficiency, patient comfort, and simplicity of use as their top priorities. The company demonstrates an immense will to develop its technology since it invested around USD 348.57 million in R&D in 2023. Securing 278 fresh patents over the fiscal year, it demonstrated its leadership in creating fresh ideas. These patents confirm even more the company’s role as a medical equipment innovator.
For more information, Inquire Now!
Related Reports:
Respiratory Care Devices Market
Continuous Renal Replacement Therapy Market
Get access to the latest updates on Medical Humidifier Companies and Medical Humidifier Market Size
CONTACT: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445, USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: www.marketsandmarkets.com
